Summary by Moomoo AI
Sai Seng Pharmaceuticals announced on 17 April 2024 that under Rule 22 of the Hong Kong Code of Acquisitions and Mergers, Peter Shao Chihwen, an associate of the Company, purchased 48,750 shares at a price of $0.0000 per share on 5 April 2024 through an initial public offering restricted share plan, at a price of $0.0000 per share and a post-transaction holding of 80,0,00 shares. 831 shares representing 0.0129% of the company's class securities. The transaction is a personal account transaction and was disclosed by the executors on April 17.